By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Proteostasis Therapeutics, Inc. 

200 Technology Square
Suite 402
Cambridge  Massachusetts  02139  U.S.A.
Phone: n/a Fax: n/a



Company News
Proteostasis (PTI) Achieves Preclinical Milestone In Astellas (ALPMY) Collaboration 8/9/2016 11:12:04 AM
Proteostasis (PTI) Announces Key Leadership Appointments 8/8/2016 9:48:55 AM
Proteostasis (PTI) Presents New Data Demonstrating Potential For Genotype-Agnostic And Combination Therapies For People With Cystic Fibrosis 4/1/2016 8:37:21 AM
Proteostasis (PTI) Debuts Well-Below Expected Range But Still Raises $50 Millon in IPO 2/11/2016 8:11:17 AM
Proteostasis Files for a $86 Million IPO 12/28/2015 7:34:34 AM
Proteostasis Therapeutics, Inc. Announces Management Changes To Strengthen Research And Development Organization 12/11/2015 11:11:48 AM
Proteostasis Therapeutics, Inc. Demonstrates Therapeutic Potential Of A Proprietary Triple Combination Therapy For The Treatment Of Cystic Fibrosis That Restores Activity Of Mutant F508del CFTR Protein To 80% Of Normal 11/23/2015 12:42:00 PM
Proteostasis Therapeutics, Inc. Presents Preclinical Data For Its CFTR Amplifier Program At The 29th Annual North American Cystic Fibrosis Conference 10/12/2015 11:32:41 AM
Proteostasis Therapeutics, Inc. Raises $37 Million In Crossover Financing 9/8/2015 12:19:28 PM
Proteostasis Therapeutics, Inc. Announces A New Class Of Agents For Cystic Fibrosis Called CFTR Amplifiers And Selects PTI130 As A Development Candidate 2/5/2015 10:38:49 AM